Plan B news from FiercePharma
News
FDA mulls behind-the-counter drug sales
Once, the gap between prescription drugs and over-the-counter sales was a wide No Man's Land where few products roamed. Now, the FDA may settle more medications in this country, known as Read more...
After controversy, Plan B sales strong
Like Madonna, the Plan B has faced its share of controversy. Like Hilary Clinton, it's attracted more than its share of political sniping. Like both, it's risen undeterred. Since Plan B was approved Read more...
Get more Plan B coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets